Connection

John Lemasters to Enzyme Inhibitors

This is a "connection" page, showing publications John Lemasters has written about Enzyme Inhibitors.
Connection Strength

0.333
  1. ATP/ADP Turnover and Import of Glycolytic ATP into Mitochondria in Cancer Cells Is Independent of the Adenine Nucleotide Translocator. J Biol Chem. 2016 09 09; 291(37):19642-50.
    View in: PubMed
    Score: 0.113
  2. Inhibition of sphingosine kinase-2 suppresses inflammation and attenuates graft injury after liver transplantation in rats. PLoS One. 2012; 7(7):e41834.
    View in: PubMed
    Score: 0.085
  3. Mitochondrial permeability transition in the switch from necrotic to apoptotic cell death in ischemic rat hepatocytes. Gastroenterology. 2003 Feb; 124(2):494-503.
    View in: PubMed
    Score: 0.044
  4. Lipopolysaccharide-stimulated TNF-alpha release from cultured rat Kupffer cells: sequence of intracellular signaling pathways. J Leukoc Biol. 1998 Sep; 64(3):368-72.
    View in: PubMed
    Score: 0.033
  5. Lysosomal signaling enhances mitochondria-mediated photodynamic therapy in A431 cancer cells: role of iron. Photochem Photobiol. 2012 Mar-Apr; 88(2):461-8.
    View in: PubMed
    Score: 0.021
  6. Sphingosine kinase-2 inhibition improves mitochondrial function and survival after hepatic ischemia-reperfusion. J Hepatol. 2012 Jan; 56(1):137-45.
    View in: PubMed
    Score: 0.020
  7. Differential requirement for c-Jun NH2-terminal kinase in TNFalpha- and Fas-mediated apoptosis in hepatocytes. FASEB J. 2004 Apr; 18(6):720-2.
    View in: PubMed
    Score: 0.012
  8. SPC-100270, a protein kinase C inhibitor, reduced hypoxic injury due to reperfusion following orthotopic liver transplantation in the rat. Transpl Int. 1994; 7 Suppl 1:S167-70.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.